KLP Kapitalforvaltning AS Makes New Investment in Oscar Health, Inc. (NYSE:OSCR)

KLP Kapitalforvaltning AS bought a new position in Oscar Health, Inc. (NYSE:OSCR) in the 4th quarter, Holdings Channel.com reports. The fund bought 33,900 shares of the company’s stock, valued at approximately $456,000.

Other large investors have also modified their holdings of the company. FMR LLC lifted its stake in Oscar Health by 29.5% during the third quarter. FMR LLC now owns 109,002 shares of the company’s stock worth $2,312,000 after purchasing an additional 24,801 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Oscar Health by 9.2% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 26,446 shares of the company’s stock worth $561,000 after buying an additional 2,236 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Oscar Health by 29.2% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 353,491 shares of the company’s stock worth $7,498,000 after buying an additional 79,801 shares during the last quarter. Janus Henderson Group PLC boosted its holdings in shares of Oscar Health by 27.1% in the 3rd quarter. Janus Henderson Group PLC now owns 72,236 shares of the company’s stock valued at $1,532,000 after buying an additional 15,400 shares during the period. Finally, Point72 Asset Management L.P. grew its position in shares of Oscar Health by 30.3% during the 3rd quarter. Point72 Asset Management L.P. now owns 1,212,096 shares of the company’s stock valued at $25,709,000 after buying an additional 281,858 shares during the last quarter. Institutional investors own 75.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on OSCR. Wells Fargo & Company downgraded Oscar Health from an “overweight” rating to an “equal weight” rating and decreased their target price for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Jefferies Financial Group assumed coverage on Oscar Health in a research report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective for the company. Two research analysts have rated the stock with a sell rating, three have given a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $20.21.

Oscar Health Stock Down 4.6 %

OSCR opened at $12.99 on Friday. The stock’s 50 day moving average price is $14.60 and its 200 day moving average price is $15.84. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The stock has a market cap of $3.25 billion, a P/E ratio of -649.18 and a beta of 1.75. Oscar Health, Inc. has a 12 month low of $12.25 and a 12 month high of $23.79.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.